Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.59B |
| 2 |
Microchip Technology
MCHP
|
$691M |
| 3 |
Microsoft
MSFT
|
$586M |
| 4 |
PepsiCo
PEP
|
$510M |
| 5 |
Sunoco
SUN
|
$454M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$793M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$490M |
| 3 |
NS
NuStar Energy L.P.
NS
|
$431M |
| 4 |
Flutter Entertainment
FLUT
|
$424M |
| 5 |
UDR
UDR
|
$419M |
Sector Composition
| 1 | Technology | 25.82% |
| 2 | Financials | 11.96% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 10.48% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Invivyd
IVVD
$218M
| $39.5K | ﹤0.01% |
+35,894
| New | +$39.5K |
|
3727
PDS Biotechnology
PDSB
$60.6M
| $38.6K | ﹤0.01% |
13,174
-5,355
| -29% | -$15.7K |
|
3728
Generation Bio
GBIO
$40.3M
| $37.7K | ﹤0.01% |
1,335
-208
| -13% | -$5.87K |
|
|
LUNA
3729
DELISTED
Luna Innovations Incorporated
LUNA
| $37.6K | ﹤0.01% |
11,754
-23,295
| -66% | -$74.5K |
|
|
OPTN
3730
DELISTED
OptiNose
OPTN
| $37.5K | ﹤0.01% |
2,405
+265
| +12% | +$4.13K |
|
3731
Compass Therapeutics
CMPX
$466M
| $37.4K | ﹤0.01% |
37,402
-4,361
| -10% | -$4.36K |
|
3732
RAPT Therapeutics
RAPT
$187M
| $37K | ﹤0.01% |
1,516
-175
| -10% | -$4.27K |
|
3733
Quantum-Si Incorporated
QSI
$217M
| $36.9K | ﹤0.01% |
35,186
-4,888
| -12% | -$5.13K |
|
3734
Tenaya Therapeutics
TNYA
$192M
| $36.7K | ﹤0.01% |
11,848
-78
| -0.7% | -$242 |
|
3735
Verastem
VSTM
$585M
| $36.5K | ﹤0.01% |
+12,260
| New | +$36.5K |
|
3736
Scilex Holding
SCLX
$131M
| $36.3K | ﹤0.01% |
538
| – | – |
|
3737
Karyopharm Therapeutics
KPTI
$61.4M
| $35.1K | ﹤0.01% |
2,701
+836
| +45% | +$10.9K |
|
3738
AXT Inc
AXTI
$142M
| $34.8K | ﹤0.01% |
+10,304
| New | +$34.8K |
|
3739
Nerdy
NRDY
$159M
| $34.4K | ﹤0.01% |
20,587
| – | – |
|
3740
Werewolf Therapeutics
HOWL
$62.6M
| $34.2K | ﹤0.01% |
+14,028
| New | +$34.2K |
|
|
ADAP
3741
Adaptimmune Therapeutics
ADAP
$13.9M
| $33.9K | ﹤0.01% |
+34,743
| New | +$33.9K |
|
|
VXRT
3742
DELISTED
Vaxart
VXRT
| $32.1K | ﹤0.01% |
+48,171
| New | +$32.1K |
|
3743
374Water
SCWO
$49.9M
| $31.3K | ﹤0.01% |
26,050
-3
| -0% | -$4 |
|
3744
FibroGen
FGEN
$48.4M
| $30.7K | ﹤0.01% |
1,377
-215
| -14% | -$4.8K |
|
3745
Compugen
CGEN
$133M
| $30.4K | ﹤0.01% |
+18,092
| New | +$30.4K |
|
3746
BigBear.ai
BBAI
$1.82B
| $29.6K | ﹤0.01% |
19,590
+5,300
| +37% | +$8K |
|
3747
Seres Therapeutics
MCRB
$162M
| $28.4K | ﹤0.01% |
1,963
-1,185
| -38% | -$17.2K |
|
3748
CytomX Therapeutics
CTMX
$350M
| $28.2K | ﹤0.01% |
+23,094
| New | +$28.2K |
|
3749
Ovid Therapeutics
OVID
$94.6M
| $22.2K | ﹤0.01% |
28,850
-704
| -2% | -$542 |
|
3750
System1
SST
$57.2M
| $16.5K | ﹤0.01% |
1,084
-3,590
| -77% | -$54.6K |
|